{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:43:55Z","timestamp":1790167435604,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["01BX005789"],"award-info":[{"award-number":["01BX005789"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009238","name":"Virginia Commonwealth University","doi-asserted-by":"publisher","award":["MRI2022\\u201301"],"award-info":[{"award-number":["MRI2022\\u201301"]}],"id":[{"id":"10.13039\/100009238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009238","name":"Virginia Commonwealth University","doi-asserted-by":"publisher","award":["TTP-021\\u2013023"],"award-info":[{"award-number":["TTP-021\\u2013023"]}],"id":[{"id":"10.13039\/100009238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.phrs.2025.108075","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T22:57:47Z","timestamp":1766876267000},"page":"108075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery, development, and characterization of potent and selective USP11 inhibitors"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2646-3623","authenticated-orcid":false,"given":"Forum","family":"Kayastha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah B.","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Roychowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid M.","family":"Nanaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Sok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen E.","family":"Kellogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandish","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald B.","family":"Gartenhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.108075_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcdb.2023.08.002","article-title":"Proteotoxic stress and the ubiquitin proteasome system","volume":"156","author":"Kandel","year":"2024","journal-title":"Semin Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2025.108075_bib2","first-page":"9963905","article-title":"The dual role of USP11 in cancer","author":"Guo","year":"2022","journal-title":"J. Oncol. 2022"},{"issue":"3","key":"10.1016\/j.phrs.2025.108075_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101077","article-title":"Deubiquitinating enzymes (DUBs): regulation, homeostasis, and oxidative stress response","volume":"297","author":"Snyder","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2025.108075_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2021.103261","article-title":"Damsel in distress calling on her knights: Illuminating the pioneering role of E3 ubiquitin ligases in guarding the genome integrity","volume":"109","author":"Sahay","year":"2022","journal-title":"DNA Repair"},{"issue":"3","key":"10.1016\/j.phrs.2025.108075_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1204","article-title":"The roles of E3 ubiquitin ligases in cancer progression and targeted therapy","volume":"13","author":"Sampson","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"2","key":"10.1016\/j.phrs.2025.108075_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrc.2017.105","article-title":"Ubiquitin ligases in oncogenic transformation and cancer therapy","volume":"18","author":"Senft","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"14","key":"10.1016\/j.phrs.2025.108075_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143547","article-title":"Deubiquitinases in cancers: aspects of proliferation, metastasis, and apoptosis","volume":"14","author":"Liu","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.phrs.2025.108075_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.trecan.2019.08.005","article-title":"DUBs, hypoxia, and cancer","volume":"5","author":"Mennerich","year":"2019","journal-title":"Trends Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.phrs.2025.108075_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70036","article-title":"Deubiquitinases as novel therapeutic targets for diseases","volume":"5","author":"Xian","year":"2024","journal-title":"MedComm"},{"issue":"9","key":"10.1016\/j.phrs.2025.108075_bib11","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.drudis.2022.06.009","article-title":"Deubiquitinating enzymes: promising targets for drug resistance","volume":"27","author":"Ge","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.phrs.2025.108075_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12862-015-0511-1","article-title":"Evolution of the highly networked deubiquitinating enzymes USP4, USP15, and USP11","volume":"15","author":"Vlasschaert","year":"2015","journal-title":"BMC Evol. Biol."},{"issue":"18","key":"10.1016\/j.phrs.2025.108075_bib13","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1093\/nar\/gkz726","article-title":"USP11 acts as a histone deubiquitinase functioning in chromatin reorganization during DNA repair","volume":"47","author":"Ting","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41467-018-03028-y","article-title":"Fatty Acid Synthase induced S6Kinase facilitates USP11-eIF4B complex formation for sustained oncogenic translation in DLBCL","volume":"9","author":"Kapadia","year":"2018","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.phrs.2025.108075_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105300","article-title":"Ubiquitin-specific protease 11 structure in complex with an engineered substrate mimetic reveals a molecular feature for deubiquitination selectivity","volume":"299","author":"Maurer","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2025.108075_bib16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1074\/jbc.RA118.004469","article-title":"Discovery of peptide ligands targeting a specific ubiquitin-like domain-binding site in the deubiquitinase USP11","volume":"294","author":"Spiliotopoulos","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.phrs.2025.108075_bib17","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/j.febslet.2011.09.040","article-title":"Structural variability of the ubiquitin specific protease DUSP-UBL double domains","volume":"585","author":"Elliott","year":"2011","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41420-022-01083-5","article-title":"Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management","volume":"8","author":"Liao","year":"2022","journal-title":"Cell Death Discov."},{"issue":"8","key":"10.1016\/j.phrs.2025.108075_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221721","article-title":"High A20 expression negatively impacts survival in patients with breast cancer","volume":"14","author":"Yoon","year":"2019","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.phrs.2025.108075_bib20","doi-asserted-by":"crossref","first-page":"6976","DOI":"10.1111\/jcmm.16709","article-title":"USP11 degrades KLF4 via its deubiquitinase activity in liver diseases","volume":"25","author":"Yang","year":"2021","journal-title":"J. Cell Mol. Med"},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2021.101779","article-title":"Inhibition of USP11 sensitizes gastric cancer to chemotherapy via suppressing RhoA and Ras-mediated signaling pathways","volume":"46","author":"Liu","year":"2022","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"7","key":"10.1016\/j.phrs.2025.108075_bib22","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1158\/1541-7786.MCR-17-0723","article-title":"USP11 enhances TGFbeta-induced epithelial-mesenchymal plasticity and human breast cancer metastasis","volume":"16","author":"Garcia","year":"2018","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2025.108075_bib23","first-page":"1739","article-title":"Upregulation of USP11 promotes epithelial\u2011to\u2011mesenchymal transition by deubiquitinating Snail in ovarian cancer","volume":"41","author":"Wang","year":"2019","journal-title":"Oncol. Rep."},{"issue":"23","key":"10.1016\/j.phrs.2025.108075_bib24","doi-asserted-by":"crossref","first-page":"15681","DOI":"10.1074\/jbc.M708278200","article-title":"USP11 stabilizes HPV-16E7 and further modulates the E7 biological activity","volume":"283","author":"Lin","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2025.108075_bib25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1592\/phco.30.9.904","article-title":"Dronedarone: a new antiarrhythmic agent","volume":"30","author":"Oyetayo","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"7-8","key":"10.1016\/j.phrs.2025.108075_bib26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0223-5234(00)00167-7","article-title":"Hydrophobicity: is LogP(o\/w) more than the sum of its parts?","volume":"35","author":"Kellogg","year":"2000","journal-title":"Eur. J. Med Chem."},{"issue":"18","key":"10.1016\/j.phrs.2025.108075_bib27","doi-asserted-by":"crossref","first-page":"7382","DOI":"10.1021\/jm400954h","article-title":"How to deal with low-resolution target structures: using SAR, ensemble docking, hydropathic analysis, and 3D-QSAR to definitively map the alphabeta-tubulin colchicine site","volume":"56","author":"Da","year":"2013","journal-title":"J. Med Chem."},{"issue":"18","key":"10.1016\/j.phrs.2025.108075_bib28","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1021\/jm030596b","article-title":"Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 3. The free energy contribution of structural water molecules in HIV-1 protease complexes","volume":"47","author":"Fornabaio","year":"2004","journal-title":"J. Med Chem."},{"issue":"13","key":"10.1016\/j.phrs.2025.108075_bib29","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2174\/1568026616999151012120106","article-title":"Advances in drug discovery for the treatment of cancer: many approaches, one goal","volume":"16","author":"Bowen","year":"2016","journal-title":"Curr. Top. Med Chem."},{"issue":"11","key":"10.1016\/j.phrs.2025.108075_bib30","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","article-title":"ZINC 15--ligand discovery for everyone","volume":"55","author":"Sterling","year":"2015","journal-title":"J. Chem. Inf. Model"},{"issue":"3","key":"10.1016\/j.phrs.2025.108075_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2025.108075_bib32","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/jcc.540100804","article-title":"Validation of the general purpose tripos 5.2 force field","volume":"10","author":"Clark","year":"1989","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.gendis.2020.10.004","article-title":"The USP7 protein interaction network and its roles in tumorigenesis","volume":"9","author":"Al-Eidan","year":"2022","journal-title":"Genes Dis."},{"issue":"18","key":"10.1016\/j.phrs.2025.108075_bib34","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1021\/bi500116x","article-title":"Structure and catalytic regulatory function of ubiquitin specific protease 11 N-terminal and ubiquitin-like domains","volume":"53","author":"Harper","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2025.108075_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-015-0218-1","article-title":"Establishment and characterization of a novel MYC\/BCL2 \"double-hit\" diffuse large B cell lymphoma cell line, RC","volume":"8","author":"Pham","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"99","key":"10.1016\/j.phrs.2025.108075_bib36","doi-asserted-by":"crossref","DOI":"10.3791\/52784","article-title":"Method for measuring the activity of deubiquitinating enzymes in cell lines and tissue samples","author":"Griffin","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s10020-022-00534-0","article-title":"Novel eIF4A1 inhibitors with anti-tumor activity in lymphoma","volume":"28","author":"Kayastha","year":"2022","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2025.108075_bib38","first-page":"75","article-title":"Lymphoblastoid cell lines: a continuous in vitro source of cells to study carcinogen sensitivity and DNA repair","volume":"1","author":"Hussain","year":"2012","journal-title":"Int. J. Mol. Cell Med."},{"issue":"W1","key":"10.1016\/j.phrs.2025.108075_bib39","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.phrs.2025.108075_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv388","article-title":"NCI-60 cell line screening: a radical departure in its time","volume":"108","author":"Chabner","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"7749","key":"10.1016\/j.phrs.2025.108075_bib41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41586-019-1030-9","article-title":"Recruitment of BRCA1 limits MYCN-driven accumulation of stalled RNA polymerase","volume":"567","author":"Herold","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2025.108075_bib42","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/leu.2010.6","article-title":"\u03b3H2AX: a sensitive molecular marker of DNA damage and repair","volume":"24","author":"Mah","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.phrs.2025.108075_bib43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/europace\/euab262","article-title":"International cohort study on the effectiveness of dronedarone and other antiarrhythmic drugs for atrial fibrillation in real-world practice (EFFECT-AF)","volume":"24","author":"Khachatryan","year":"2022","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.phrs.2025.108075_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.phrs.2025.108075_bib45","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004317","article-title":"Endoplasmic-reticulum calcium depletion and disease","volume":"3","author":"Mekahli","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2025.108075_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091077","article-title":"Advances in intracellular calcium signaling reveal untapped targets for cancer therapy","volume":"9","author":"Sharma","year":"2021","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.phrs.2025.108075_bib47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41589-019-0256-z","article-title":"An orange calcium-modulated bioluminescent indicator for non-invasive activity imaging","volume":"15","author":"Oh","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.phrs.2025.108075_bib48","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: multiple ligand-protein interaction diagrams for drug discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model"},{"issue":"Pt 2","key":"10.1016\/j.phrs.2025.108075_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.semcancer.2020.03.008","article-title":"Dissenting degradation: deubiquitinases in cell cycle and cancer","volume":"67","author":"Bonacci","year":"2020","journal-title":"Semin Cancer Biol."},{"issue":"36","key":"10.1016\/j.phrs.2025.108075_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303807","article-title":"Deubiquitylating Enzymes in Cancer and Immunity","volume":"10","author":"Ren","year":"2023","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2025.108075_bib51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.chembiol.2018.10.022","article-title":"From discovery to bedside: targeting the ubiquitin system","volume":"26","author":"Wertz","year":"2019","journal-title":"Cell Chem. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2025.108075_bib52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/BST20190535","article-title":"Small molecules that target the ubiquitin system","volume":"48","author":"Wu","year":"2020","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.phrs.2025.108075_bib53","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-21-0729","article-title":"PARK2 regulates eIF4B-driven lymphomagenesis","author":"Kapadia","year":"2022","journal-title":"Mol. Cancer Res."},{"issue":"10","key":"10.1016\/j.phrs.2025.108075_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078979","article-title":"RSK activation of translation factor eIF4B drives abnormal increases of laminin gamma2 and MYC protein during neoplastic progression to squamous cell carcinoma","volume":"8","author":"Degen","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.phrs.2025.108075_bib55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.celrep.2012.02.010","article-title":"Targeting synthetic lethal interactions between Myc and the eIF4F complex impedes tumorigenesis","volume":"1","author":"Lin","year":"2012","journal-title":"Cell Rep."},{"issue":"13","key":"10.1016\/j.phrs.2025.108075_bib56","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1158\/0008-5472.CAN-07-5876","article-title":"c-Myc and eIF4F are components of a feedforward loop that links transcription and translation","volume":"68","author":"Lin","year":"2008","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.phrs.2025.108075_bib57","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1074\/jbc.M110.104745","article-title":"Sensitivity to poly(ADP-ribose) polymerase (PARP) inhibition identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of DNA double-strand break repair","volume":"285","author":"Wiltshire","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2025.108075_bib58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41388-023-02847-8","article-title":"USP11 potentiates HGF\/AKT signaling and drives metastasis in hepatocellular carcinoma","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"issue":"45","key":"10.1016\/j.phrs.2025.108075_bib59","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1038\/s41388-021-02025-8","article-title":"Calcium-dependent signalling in B-cell lymphomas","volume":"40","author":"Berditchevski","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.phrs.2025.108075_bib60","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.clml.2017.12.006","article-title":"Mechanisms of hypercalcemia in non-hodgkin lymphoma and associated outcomes: a retrospective review","volume":"18","author":"Shallis","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"3","key":"10.1016\/j.phrs.2025.108075_bib61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4143\/crt.2014.46.3.307","article-title":"Unusual manifestation of intravascular large B-cell lymphoma: severe hypercalcemia with parathyroid hormone-related protein","volume":"46","author":"Ha","year":"2014","journal-title":"Cancer Res Treat."},{"issue":"6","key":"10.1016\/j.phrs.2025.108075_bib62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.14740\/wjon1246","article-title":"Hypercalcemia in T-cell\/histiocyte-Rich large B-cell lymphoma: an unusual presentation of a rare disease and literature review","volume":"10","author":"Conte","year":"2019","journal-title":"World J. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/CJI.0b013e3181b290f1","article-title":"Therapeutic (high) doses of rituximab activate calcium mobilization and inhibit B-cell growth via an unusual mechanism triggered independently of both CD20 and Fcgamma receptors","volume":"33","author":"Unruh","year":"2010","journal-title":"J. Immunother."},{"issue":"8","key":"10.1016\/j.phrs.2025.108075_bib64","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/1541-7786.MCR-12-0699","article-title":"Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survival","volume":"11","author":"Burkhart","year":"2013","journal-title":"Mol. Cancer Res"},{"issue":"3","key":"10.1016\/j.phrs.2025.108075_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2022.107862","article-title":"Mitoxantrone stacking does not define the active or inactive state of USP15 catalytic domain","volume":"214","author":"Priyanka","year":"2022","journal-title":"J. Struct. Biol."},{"issue":"45","key":"10.1016\/j.phrs.2025.108075_bib66","doi-asserted-by":"crossref","first-page":"17362","DOI":"10.1074\/jbc.RA118.003857","article-title":"The structure of the deubiquitinase USP15 reveals a misaligned catalytic triad and an open ubiquitin-binding channel","volume":"293","author":"Ward","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34348-0","article-title":"The antiarrhythmic drug, dronedarone, demonstrates cytotoxic effects in breast cancer independent of thyroid hormone receptor Alpha 1 (THRalpha1) antagonism","volume":"8","author":"Elliott","year":"2018","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2025.108075_bib68","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41419-024-07102-w","article-title":"Dronedarone hydrochloride (DH) induces pancreatic cancer cell death by triggering mtDNA-mediated pyroptosis","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.phrs.2025.108075_bib69","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ygyno.2018.09.019","article-title":"Evaluating class III antiarrhythmic agents as novel MYC targeting drugs in ovarian cancer","volume":"151","author":"Belur Nagaraj","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2025.108075_bib70","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s11684-024-1062-x","article-title":"Dronedarone inhibits the proliferation of esophageal squamous cell carcinoma through the CDK4\/CDK6-RB1 axis in vitro and in vivo","volume":"18","author":"Li","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.phrs.2025.108075_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102136","article-title":"Dronedarone hydrochloride inhibits gastric cancer proliferation in vitro and in vivo by targeting SRC","volume":"50","author":"Lu","year":"2024","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib72","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-020-00850-0","article-title":"The design and development of covalent protein-protein interaction inhibitors for cancer treatment","volume":"13","author":"Cheng","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","article-title":"Deubiquitinases: from mechanisms to their inhibition by small molecules","volume":"82","author":"Lange","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2025.108075_bib74","doi-asserted-by":"crossref","first-page":"1349509","DOI":"10.3389\/fmolb.2024.1349509","article-title":"In the moonlight: non-catalytic functions of ubiquitin and ubiquitin-like proteases","volume":"11","author":"Alonso","year":"2024","journal-title":"Front Mol. Biosci."},{"issue":"7","key":"10.1016\/j.phrs.2025.108075_bib75","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.apsb.2023.02.019","article-title":"Deubiquitination complex platform: a plausible mechanism for regulating the substrate specificity of deubiquitinating enzymes","volume":"13","author":"Fang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.phrs.2025.108075_bib76","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1021\/jacs.2c11098","article-title":"Advancing targeted protein degradation via multiomics profiling and artificial intelligence","volume":"145","author":"Duran-Frigola","year":"2023","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.phrs.2025.108075_bib77","first-page":"501","article-title":"Prospects for pharmacological targeting of pseudokinases","volume":"18","author":"Kung","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib78","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41392-023-01647-6","article-title":"Bromodomain and extraterminal (BET) proteins: biological functions, diseases, and targeted therapy","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"9","key":"10.1016\/j.phrs.2025.108075_bib79","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.phrs.2025.108075_bib80","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood.V99.1.310","article-title":"FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model","volume":"99","author":"Kelly","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.phrs.2025.108075_bib81","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kramer","year":"2014","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.phrs.2025.108075_bib82","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1158\/1541-7786.MCR-21-0729","article-title":"PARK2 regulates eIF4B-driven lymphomagenesis","volume":"20","author":"Kapadia","year":"2022","journal-title":"Mol. Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2025.108075_bib83","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s10616-015-9909-2","article-title":"A comparative study of colorimetric cell proliferation assays in immune cells","volume":"68","author":"Koyanagi","year":"2016","journal-title":"Cytotechnology"},{"issue":"5","key":"10.1016\/j.phrs.2025.108075_bib84","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1535-7163.MCT-10-0106","article-title":"Analysis of food and drug administration-approved anticancer agents in the NCI60 panel of human tumor cell lines","volume":"9","author":"Holbeck","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phrs.2025.108075_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.exer.2014.09.002","article-title":"Andrographolide reduces proliferation and migration of lens epithelial cells by modulating PI3K\/Akt pathway","volume":"128","author":"Kayastha","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.phrs.2025.108075_bib86","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s12038-012-9264-9","article-title":"Cx43, ZO-1, alpha-catenin and beta-catenin in cataractous lens epithelial cells","volume":"37","author":"Arora","year":"2012","journal-title":"J. Biosci."},{"issue":"50","key":"10.1016\/j.phrs.2025.108075_bib87","first-page":"48745","article-title":"Phosphorylation of transcriptional coactivator peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP)","volume":"277","author":"Misra","year":"2002","journal-title":"Stimul. Transcr. Regul. mitogenAct. Protein kinase J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2025.108075_bib88","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12038-015-9513-9","article-title":"Andrographolide suppresses epithelial mesenchymal transition by inhibition of MAPK signalling pathway in lens epithelial cells","volume":"40","author":"Kayastha","year":"2015","journal-title":"J. Biosci."},{"issue":"7","key":"10.1016\/j.phrs.2025.108075_bib89","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11095-019-2634-3","article-title":"Characterization of plasma membrane localization and phosphorylation status of organic anion transporting polypeptide (OATP) 1B1c.521 T>C nonsynonymous single-nucleotide polymorphism","volume":"36","author":"Crowe","year":"2019","journal-title":"Pharm. Res"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825005006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825005006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:24:29Z","timestamp":1773959069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825005006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":89,"alternative-id":["S1043661825005006"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108075","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery, development, and characterization of potent and selective USP11 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.108075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108075"}}